Final Program [International AIDS Society (11th: 1996: Vancouver, Canada)]

VENUE ROOM TRACK SESSION NO. TIME I SESSION PATHWAYS
III

C3 141 Track C: Epidemiology and Public Health
Crystal Abstract Session:
Pavilion Epidemiology and Risk Behaviour among IDUs in Developed Countries
Chairs:
Julie Bruneau, Canada / Wayne Wiebel, USA...............................................................................................................................................................................................................................................
Mo.C.460 15:30
DECREASING ANNUAL INCIDENCE OF HIV AMONG IDUs IN STOCKHOLM IN SPITE OF CONTINUED HIV
RISK BEHAVIOUR
Kill, Kerstin,I' julander 1,2 Krook A,2 Olin R,I Stendahl P1 ' Dept. of Social Medicine, Karolinska Institute; 2Dept. of Infectious Diseases,
Huddinge Hospital, Stockholm, Sweden................................................................................................................................................................................................................................................
Mo.C.461 15:45
UNDERSTANDING THE DYNAMICS OF HIV INFECTION AMONG INJECTING DRUG USERS IN ROME IN THE 1990s:
THE COMBINED USE OF CROSS-SECTIONAL LONGITUDINAL AND BEHAVIORAL DATA
Zaccarelli, Mauro2/3, Gattari FI Spizzichino L,' Portaleone A,I Venezia 5,I Rezza G2. 'Drug Dependency Unit RM/E, Santo Spirito
Hospital; 2AIDS Unit, Istituto Superiore di SanitA; 3Spallanzani Hospital, Rome, Italy................................................................................................................................................................................................................................................
Mo.C.462 16:00
DRUG INJECTORS' SOCIAL NETWORKS CAN BE RISK FACTORS FOR SYRINGE SHARING
Neaigus, Alan,I, Friedman SR,I Jose B,I Curtis R,' Goldstein M,' Ildefonso G,' Des Jarlais DC2. 'National Development & Research
Institutes, Inc.; 2Beth Israel Medical Center, New York, NY USA................................................................................................................................................................................................................................................
Mo.C.463 16:15
EXPLAINING AN OUTBREAK: DETERMINANTS OF HIV SEROCONVERSION AMONG INJECTION DRUG USERS
IN VANCOUVER
Patrick David M I/3, Strathdee SA2/3, Ofner M,4 Archibald CF4 Craib KJF2 Cornelisse PGA,2 Schechter MT2/3, Eades G,2 O'Shaughnessy
MV2/3, Rekart MLI/3. IBC Centre for Disease Control; 2BC Centre for Excellence in HIV/AIDS; 3University of British Columbia,
Vancouver, BC; 4Laboratory Centre for Disease Control, Ottawa, ON, Canada................................................................................................................................................................................................................................................,o Mo.C.464 16:30
S YOUNGER AGE OF INITIATING INJECTING DRUG USE IS ASSOCIATED WITH RISKY BEHAVIORS AND HIV INFECTION
5 IN SHORT-TERM INJECTORS
o Doherty Meg C,I Garfein RS,I Monterroso E,2 Brown D,I Huang H,I Park M,' Vlahov D. I The Reach Study, Johns Hopkins University,
- Baltimore, MD; 2CDC, Atlanta, GA, USA.
>...............................................................................................................................................................................................................................................
S Mo.C.465 16:45
THE RELATIVE IMPORTANCE OF YOUNG AND RECENT-ONSET INJECTION DRUG USERS IN THE AMSTERDAM
S HIV EPIDEMIC, 1986-1995
0 Fennema, Johan SA, van Ameijden EJC, van den Hoek JAR, Coutinho RA. Municipal Health Service, Dept. of Public Health and
a)
U Environment, Amsterdam,The Netherlands.
O
U
c
0
sO
c
C

96